Intuit Earnings Results Challenge Morgan Stanleys Stock Outlook Foresight Ventures Leads 30M Investment in PopDEX Targeting TraderCentric Perpetual DEX Innovation Novartis Raises FullYear Sales and Profit Outlook National Music Centre Appoints Steve Kane as Board Chair Announces Board Updates DA Davidson Adjusts Roblox Price Target Amid Market Evaluation Trumps Iran Deal Dissatisfaction What It Means for Geopolitical Risk and Oil Markets Reeds Inc REED Q1 2026 Earnings WiderthanExpected Loss Sends Stock Higher Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher MaxCyte Q1 2026 Earnings EPS Beat Highlights Operational Cost Discipline Amid Revenue Disclosure Gaps United Security Bancshares UBFO Q4 2025 Earnings EPS of 019 Reported Stock Unchanged Zentalis Pharmaceuticals ZNTL Rises 152 as Stock Tests Key Resistance Firefly Neuroscience AIFF Slides 116 as Traders Eye Key 162 Support Level AdaptHealth Corp AHCO Declines Slightly Holding Near Key Support Zone Baidu BIDU Rallies 3 on Strong Volume Nears Critical Resistance at 13718 Northrop Grumman NOC Slides Slightly as Defense Sector Faces Mixed Sentiment Geopolitical Risk Irans Suspicion of US Ceasefire Terms Adds Uncertainty for Energy Markets BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 104 Alliancebernstein Global High Income Fund AWF Edges Higher as Bond Market Stabilizes EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Rally Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response OSS Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally THO Q1 2026 Earnings Massive EPS Surprise of 831 Drives Stock Higher AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available PARR Q1 2026 Earnings Earnings Miss Weighs on Results but Stock Edges Higher BriaCell Therapeutics Q1 2026 Earnings NarrowerthanExpected EPS Loss Despite No Revenue